- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Global University Venturing
Exicure extrapolates $31.3m
Northwestern University spinout Exicure, formerly known as AuraSense Therapeutics, has added $11.2m to its latest funding round with contributions from Purple Arch Ventures.
Nov 7, 2017Topas tops up series A
Topas has closed its series A round at nearly $21m, following a $4.6m extension that will be used to advance potential autoimmune disease therapies towards clinical trials.
Nov 6, 2017Instart Logic finishes $30m round
The Stanford-StartX fund-backed cloud computing optimisation platform has brought in $30m in a round that took its total funding to $140m.
Nov 6, 2017Spero hits public markets with $77m IPO
The bacterial infections drug developer, based on research at Harvard Medical School, has gone public.
Nov 6, 20173YourMind erects $12m series A
Unternehmertum Venture Capital Partners has taken part in a $12m series A round for 3YourMind, an additive manufacturing spinout of Technical University of Berlin.
Nov 6, 2017Seven reasons you should choose technology transfer as your next career
Dipanjan Nag provides an insight into technology transfer as a profession and offers seven reasons why you should consider one.
Nov 6, 2017News round up 6 November 2017
A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.
Nov 3, 2017Hebrew University and Fraunhofer screen accelerator
The two institutions have chosen 16 cybersecurity teams from Israel and Germany to receive almost three months of training.
Nov 3, 2017Cronin investigates OpenIOLabs for $615,000
OpenIOLabs has been bought by diversified scientific research firm Cronin in a $615,000 all-shares deal.
Nov 3, 2017Riverfield operates $10.1m series B
The Tokyo Institute of Technology spinout has raised $10.1m to continue development of its medical robot that assist surgeons during delicate procedures.
Nov 3, 2017Reglagene shortens cancer cell life
The spinout will develop research on drugs that could one day shorten the lifespan of cancerous cells.
Nov 2, 2017UA targets pain with Regulonix
The Arizona spinout is searching for non-opioid painkillers that target sections of the nerve cell membrane thought responsible for pain disorders.
Nov 2, 2017Featured Content
University Venture Funds: The ListThe definitive list of university venture funds around the worldUniversity Venture Funds: The List
The definitive list of university venture funds around the world
Special ReportCorporate collaboration with universities: How to commercialise innovative researchSpecial Report
Corporate collaboration with universities: How to commercialise innovative research
Beyond the Breakthrough PodcastExplore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?Beyond the Breakthrough Podcast
Explore the BTB podcast archive with the world's brightest minds in university innovation answering the question: how does research make it from a lab into the real world?
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


